Literature DB >> 16460442

Int22h-related inversions causing hemophilia A: a novel insight into their origin and a new more discriminant PCR test for their detection.

R D Bagnall1, F Giannelli, P M Green.   

Abstract

BACKGROUND: Intrachromosomal, homologous recombination of the duplicon int22h-1 with int22h-2 or int22h-3 causes inversions accounting for 45% of severe hemophilia A, hence the belief that int22h-2 and int22h-3 are in opposite orientation to int22h-1. However, inversions involving int22h-2 are five times rarer than those involving its virtually identical copy: int22h-3. Recent sequencing has indicated that int22h-2 and int22h-3 form the internal part of the arms of an imperfect palindrome so that int22h-2, in the centromeric arm, has the same orientation as int22h-1 and, upon recombination with int22h-1, should produce deletions and duplications but not inversions. AIM: This work aims to provide rapid tests for all the mutations that can result from recombinations between the int22h sequences and to investigate whether int22h-2-related inversions causing hemophilia A arise in chromosomes, where the arms of the palindrome have recombined so that int22h-2 and int22h-3 swap places and orientation. PATIENTS/
METHODS: Twenty patients with int22h-related inversions were examined together with a control and inversion carriers using reverse transcription-polymerase chain reaction (RT-PCR), long-range PCR and sequencing. RESULTS AND
CONCLUSIONS: Analysis of mRNA in patients and a control provided evidence confirming the palindromic arrangement of int22h-2 and int22h-3 and the proposed inversion polymorphism that allows int22h-2 to be in the telomeric arm of the palindrome and in opposite orientation to int22h-1. New long-range PCR reactions were used to develop a single tube test that detects and discriminates inversions involving int22h-2 or int22h-3 and a two-tube test that can distinguish inversions, deletions, and duplications due to recombination between int22h sequences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460442     DOI: 10.1111/j.1538-7836.2006.01840.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  17 in total

Review 1.  Genetic testing in bleeding disorders.

Authors:  C de Brasi; O El-Maarri; D J Perry; J Oldenburg; B Pezeshkpoor; A Goodeve
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

2.  Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers.

Authors:  Irena Hudecova; Peiyong Jiang; Joanna Davies; Y M Dennis Lo; Rezan A Kadir; Rossa W K Chiu
Journal:  Blood       Date:  2017-05-10       Impact factor: 22.113

3.  Eradication of factor VIII inhibitors in patients with mild and moderate hemophilia A.

Authors:  Christine L Kempton; Geoff Allen; Jeffrey Hord; Rebecca Kruse-Jarres; Rajiv K Pruthi; Christopher Walsh; Guy Young; J Michael Soucie
Journal:  Am J Hematol       Date:  2012-06-26       Impact factor: 10.047

4.  Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative.

Authors:  Jill M Johnsen; Shelley N Fletcher; Haley Huston; Sarah Roberge; Beth K Martin; Martin Kircher; Neil C Josephson; Jay Shendure; Sarah Ruuska; Marion A Koerper; Jaime Morales; Glenn F Pierce; Diane J Aschman; Barbara A Konkle
Journal:  Blood Adv       Date:  2017-05-18

5.  Accurate, simple, and inexpensive assays to diagnose F8 gene inversion mutations in hemophilia A patients and carriers.

Authors:  Debargh Dutta; Devi Gunasekera; Margaret V Ragni; Kathleen P Pratt
Journal:  Blood Adv       Date:  2016-12-14

6.  Intron 22 homologous regions are implicated in exons 1-22 duplications of the F8 gene.

Authors:  Nathalie Lannoy; Bernard Grisart; Stéphane Eeckhoudt; Christine Verellen-Dumoulin; Catherine Lambert; Miikka Vikkula; Cédric Hermans
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

7.  Genotyping of Intron Inversions and Point Mutations in Exon 14 of the FVIII Gene in Iranian Azeri Turkish Families with Hemophilia A.

Authors:  Mahmoud Shekari Khaniani; Abdollah Ebrahimi; Setareh Daraei; Sima Mansoori Derakhshan
Journal:  Indian J Hematol Blood Transfus       Date:  2016-06-27       Impact factor: 0.900

8.  In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case-control study.

Authors:  C L Kempton; J M Soucie; C H Miller; C Hooper; M A Escobar; A J Cohen; N S Key; A R Thompson; T C Abshire
Journal:  J Thromb Haemost       Date:  2010-10       Impact factor: 5.824

9.  HLA-DRB1-factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study.

Authors:  Christine L Kempton; Amanda B Payne
Journal:  Blood Adv       Date:  2018-07-24

10.  Complexity and diversity of F8 genetic variations in the 1000 genomes.

Authors:  J N Li; I G Carrero; J F Dong; F L Yu
Journal:  J Thromb Haemost       Date:  2015-10-20       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.